2010 Fiscal Year Final Research Report
Anti-tumor vaccine by the use of antigen targeting to lectins expressed on dendritic cells
| Project/Area Number |
21790144
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
DENDA Kaori The University of Tokyo, 大学院・薬学系研究科, 助教 (00313122)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Keywords | 樹状細胞 / レクチン / ターゲティング / 抗腫瘍ワクチン / 糖鎖 |
|---|
| Research Abstract |
The subcutaneous injection of anti-MGL2 monoclonal antibodies successfully targeted antigens to the cells expressing MGL2 in mice. The antigens taken up through MGL2 were presented to antigen-specific CD4^+ T cells and led to an efficient antibody response. Since mouse MGL2 is thought to be a human MGL ortholog, these results are suggested to be able to apply to the development of novel vaccine.
|
Research Products
(30 results)
-
-
-
-
[Journal Article] Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b) : Efficient uptake and presentation of glycosylated antigens by dendritic cells.2010
Author(s)
Denda-Nagai K, Aida S, Saba K, Suzuki K, Moriyama S, Oo-Puthinan S, Tsuiji M, Morikawa A, Kumamoto Y, Sugiura D, Kudo A, Akimoto Y, Kawakami H, Bovin NV, Irimura T.
-
Journal Title
J Biol Chem. 285
Pages: 19193-19204
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
